MedPath
FDA Approval

Chlorhexidine Gluconate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 23, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Chlorhexidine(0.12 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Xttrium Laboratories, Inc.

007470579

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Xttrium Laboratories, Inc.`

Xttrium Laboratories, Inc.

Xttrium Laboratories, Inc.

007470579

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Chlorhexidine Gluconate

Product Details

NDC Product Code
0116-0101
Application Number
ANDA077789
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 23, 2020
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
PEG-40 SORBITAN DIISOSTEARATEInactive
Code: JL4CCU7I1GClass: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: MOR84MUD8EClass: ACTIBQuantity: 0.12 mg in 1 mL
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBDClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
© Copyright 2025. All Rights Reserved by MedPath